Safety and clinical efficacy of toripalimab, a PD-1 mAb, in patients with advanced or recurrent malignancies in a phase I study

Jianliang Yang, Yuankai Shi, Sheng Yang et al.|European Journal of Cancer|2020

Cited by 70